Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors: = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Erlangen ; Nürnberg
[2018]
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | 280 Seiten Illustrationen, Diagramme 21 cm |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV045864223 | ||
003 | DE-604 | ||
005 | 20190816 | ||
007 | t | ||
008 | 190507s2018 gw a||| m||| 00||| eng d | ||
015 | |a 19,H05 |2 dnb | ||
016 | 7 | |a 1182460232 |2 DE-101 | |
020 | |c Broschur | ||
035 | |a (OCoLC)1113833074 | ||
035 | |a (DE-599)DNB1182460232 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-29T |a DE-29 |a DE-355 | ||
084 | |a 540 |2 sdnb | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Schwalbe, Tobias |d 1988- |e Verfasser |0 (DE-588)1182461255 |4 aut | |
245 | 1 | 0 | |a Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors |b = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |c vorgelegt von Tobias Schwalbe |
246 | 1 | 3 | |a Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
246 | 1 | 1 | |a Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
264 | 1 | |a Erlangen ; Nürnberg |c [2018] | |
300 | |a 280 Seiten |b Illustrationen, Diagramme |c 21 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Friedrich-Alexander-Universität Erlangen-Nürnberg |d 2018 | ||
650 | 0 | 7 | |a Agonist |0 (DE-588)4380725-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Bifunktionelle Verbindungen |0 (DE-588)4298742-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Beta-Rezeptor |0 (DE-588)4144967-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Dopaminantagonist |0 (DE-588)4299915-7 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
689 | 0 | 0 | |a Dopaminantagonist |0 (DE-588)4299915-7 |D s |
689 | 0 | 1 | |a Beta-Rezeptor |0 (DE-588)4144967-8 |D s |
689 | 0 | 2 | |a Agonist |0 (DE-588)4380725-2 |D s |
689 | 0 | 3 | |a Bifunktionelle Verbindungen |0 (DE-588)4298742-8 |D s |
689 | 0 | |5 DE-604 | |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u http://d-nb.info/1182460232/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=031247646&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-031247646 |
Datensatz im Suchindex
_version_ | 1804180003473063936 |
---|---|
adam_text | TABLE
OF
CONTENTS
1.
INTRODUCTION
.................................................................................................................................
1
1.1.
G
PROTEIN
COUPLED
RECEPTORS
.................................................................................................
2
1.1.1.
P-ADRENERGIC
RECEPTORS
..........................................................................................................
2
1.1.2.
DOPAMINERGIC
RECEPTORS
........................................................................................................
4
1.1.3.
RHODOPSIN
-
A
PROTOTYPE
OF
A
NATURAL
COVALENT
LIGAND-RECEPTOR
COMPLEX
...........................
4
1.2.
COVALENTLY
BINDING
PROBES
FOR
G
PROTEIN
COUPLED
RECEPTORS
...............................................
5
1.2.1.
THE
SCOPE
OF
COVALENTLY BINDING
PROBES
FOR
GPCRS
..............................................................
6
1.2.2.
CHEMOREACTIVE
PROBES
FOR
ADRENERGIC
AND
DOPAMINERGIC
RECEPTORS
..................................
6
2.
OBJECTIVES
OF
THE
THESIS
................................................................................................................
10
3.
DEVELOPMENT
OF
A
COVALENTLY
BINDING
PARTIAL
AGONIST
FOR
THE
P
2
AR
.........................................
13
3.1.
RATIONAL
DESIGN
.....................................................................................................................
13
3.2.
SYNTHESIS
...............................................................................................................................
15
3.3.
RADIOLIGAND
BINDING
STUDIES
................................................................................................24
3.4.
RADIOLIGAND
DEPLETION
EXPERIMENTS
...................................................................................
25
3.5.
FUNCTIONAL
CHARACTERIZATION
.................................................................................................
26
4.
DESIGN
AND
SYNTHESIS
OF
COVALENTLY
BINDING
P-AR
ANTAGONISTS
................................................
29
4.1. RATIONAL
DESIGN
....................................................................................................................
29
4.2.
SYNTHESIS
...............................................................................................................................
30
4.3. RADIOLIGAND
BINDING
STUDIES
.................................................................................................41
4.4. RADIOLIGAND
DEPLETION
ASSAYS
..............................................................................................
43
5.
IRREVERSIBLY
BINDING
ANTAGONIST
FOR
THE
DOPAMINE
RECEPTOR
D
2
R
BASED
ON
HALOPERIDOL
.......47
5.1.
RATIONAL
DESIGN
....................................................................................................................
47
5.2.
SYNTHESIS
...............................................................................................................................48
5.3.
RADIOLIGAND
BINDING
STUDIES
.................................................................................................
54
5.4.
RADIOLIGAND
DEPLETION
EXPERIMENTS
...................................................................................
56
5.5.
COMPUTATIONAL
DOCKING
.......................................................................................................
58
6.
SYNTHESIS
OF
POTENTIALLY
BIAS
INDUCING
SALMETEROL
DERIVATIVES
FOR
THE
P
2
AR
...........................60
6.1.
RATIONAL
DESIGN
....................................................................................................................
60
6.2.
SYNTHESIS
...............................................................................................................................
60
6.3.
RADIOLIGAND
BINDING
STUDIES
.................................................................................................
63
6.4.
FUNCTIONAL
CHARACTERIZATION
.................................................................................................
64
7.
SYNTHESIS
OF
NORADRENALINE
ANALOGS
FOR
THE
DEVELOPMENT
OF
DNA
NANOSWITCHES
................
67
7.1.
RATIONAL
DESIGN
....................................................................................................................
67
7.2.
SYNTHESIS
..............................................................................................................................
68
7.3.
RADIOLIGAND
BINDING
STUDIES
................................................................................................
70
8.
INVESTIGATIONS
ON
THE
REACTIVITY
OF
DERIVATIVES
OF
THE
P-AR
ANTAGONIST
(S)-PROPRANOLOL
BEARING
VARIOUS
CHEMOREACTIVE
BINDING
GROUPS................................................................................
71
8.1.
RATIONAL
DESIGN
....................................................................................................................
71
8.2.
SYNTHESIS
..............................................................................................................................
73
8.3.
RADIOLIGAND
BINDING
STUDIES
.................................................................................................
77
8.4.
RADIOLIGAND
DEPLETION
EXPERIMENTS
.....................................................................................
79
9.
REVERSIBLE
AND
IRREVERSIBLE
P-AR
LIGANDS
TO
PROMOTE
THE
DEVELOPMENT
OF
NOVEL
COVALENT,
FLUORESCENT
LIGANDS
..............................................................................................................................
84
9.1.
RATIONAL
DESIGN
....................................................................................................................84
9.2.
SYNTHESIS
..............................................................................................................................
87
9.3.
RADIOLIGAND
BINDING
STUDIES
................................................................................................
91
9.4.
RADIOLIGAND
DEPLETION
EXPERIMENTS
...................................................................................
93
10.
SUMMARY
......................................................................................................................................97
11.
ZUSAMMENFASSUNG
....................................................................................................................
106
12.
EXPERIMENTAL
SECTION................................................................................................................
116
12.1.
MATERIAL
AND
METHODS
......................................................................................................
116
12.2.
CHEMICAL
REACTIVITY
STUDIES
...............................................................................................
119
12.3.
EXPERIMENTAL
PROCEDURES
AND
COMPOUND
CHARACTERIZATION
...........................................
121
13.
REFERENCES
..................................................................................................................................
260
14.
APPENDIX
....................................................................................................................................273
15.
CURRICULUM
VITAE
..................................................................................................................280
|
any_adam_object | 1 |
author | Schwalbe, Tobias 1988- |
author_GND | (DE-588)1182461255 |
author_facet | Schwalbe, Tobias 1988- |
author_role | aut |
author_sort | Schwalbe, Tobias 1988- |
author_variant | t s ts |
building | Verbundindex |
bvnumber | BV045864223 |
ctrlnum | (OCoLC)1113833074 (DE-599)DNB1182460232 |
discipline | Chemie / Pharmazie Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02301nam a2200493 c 4500</leader><controlfield tag="001">BV045864223</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190816 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">190507s2018 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,H05</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1182460232</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1113833074</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1182460232</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">540</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schwalbe, Tobias</subfield><subfield code="d">1988-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1182461255</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors</subfield><subfield code="b">= Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren</subfield><subfield code="c">vorgelegt von Tobias Schwalbe</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">280 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="d">2018</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Agonist</subfield><subfield code="0">(DE-588)4380725-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bifunktionelle Verbindungen</subfield><subfield code="0">(DE-588)4298742-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Rezeptor</subfield><subfield code="0">(DE-588)4144967-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dopaminantagonist</subfield><subfield code="0">(DE-588)4299915-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Dopaminantagonist</subfield><subfield code="0">(DE-588)4299915-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Beta-Rezeptor</subfield><subfield code="0">(DE-588)4144967-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Agonist</subfield><subfield code="0">(DE-588)4380725-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Bifunktionelle Verbindungen</subfield><subfield code="0">(DE-588)4298742-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1182460232/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=031247646&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031247646</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV045864223 |
illustrated | Illustrated |
indexdate | 2024-07-10T08:28:51Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031247646 |
oclc_num | 1113833074 |
open_access_boolean | |
owner | DE-29T DE-29 DE-355 DE-BY-UBR |
owner_facet | DE-29T DE-29 DE-355 DE-BY-UBR |
physical | 280 Seiten Illustrationen, Diagramme 21 cm |
publishDate | 2018 |
publishDateSearch | 2018 |
publishDateSort | 2018 |
record_format | marc |
spelling | Schwalbe, Tobias 1988- Verfasser (DE-588)1182461255 aut Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren vorgelegt von Tobias Schwalbe Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren Erlangen ; Nürnberg [2018] 280 Seiten Illustrationen, Diagramme 21 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Friedrich-Alexander-Universität Erlangen-Nürnberg 2018 Agonist (DE-588)4380725-2 gnd rswk-swf Bifunktionelle Verbindungen (DE-588)4298742-8 gnd rswk-swf Beta-Rezeptor (DE-588)4144967-8 gnd rswk-swf Dopaminantagonist (DE-588)4299915-7 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Dopaminantagonist (DE-588)4299915-7 s Beta-Rezeptor (DE-588)4144967-8 s Agonist (DE-588)4380725-2 s Bifunktionelle Verbindungen (DE-588)4298742-8 s DE-604 B:DE-101 application/pdf http://d-nb.info/1182460232/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=031247646&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Schwalbe, Tobias 1988- Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren Agonist (DE-588)4380725-2 gnd Bifunktionelle Verbindungen (DE-588)4298742-8 gnd Beta-Rezeptor (DE-588)4144967-8 gnd Dopaminantagonist (DE-588)4299915-7 gnd |
subject_GND | (DE-588)4380725-2 (DE-588)4298742-8 (DE-588)4144967-8 (DE-588)4299915-7 (DE-588)4113937-9 |
title | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
title_alt | Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
title_auth | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
title_exact_search | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
title_full | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren vorgelegt von Tobias Schwalbe |
title_fullStr | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren vorgelegt von Tobias Schwalbe |
title_full_unstemmed | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren vorgelegt von Tobias Schwalbe |
title_short | Synthesis and characterization of bifunctional ligands for β-adrenergic and dopamine D2 receptors |
title_sort | synthesis and characterization of bifunctional ligands for β adrenergic and dopamine d2 receptors synthese und charakterisierung bifunktionaler liganden fur β adrenerge und dopamin d2 rezeptoren |
title_sub | = Synthese und Charakterisierung bifunktionaler Liganden für β-adrenerge und Dopamin D2 Rezeptoren |
topic | Agonist (DE-588)4380725-2 gnd Bifunktionelle Verbindungen (DE-588)4298742-8 gnd Beta-Rezeptor (DE-588)4144967-8 gnd Dopaminantagonist (DE-588)4299915-7 gnd |
topic_facet | Agonist Bifunktionelle Verbindungen Beta-Rezeptor Dopaminantagonist Hochschulschrift |
url | http://d-nb.info/1182460232/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=031247646&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT schwalbetobias synthesisandcharacterizationofbifunctionalligandsforbadrenergicanddopamined2receptorssyntheseundcharakterisierungbifunktionalerligandenfurbadrenergeunddopamind2rezeptoren AT schwalbetobias syntheseundcharakterisierungbifunktionalerligandenfurbadrenergeunddopamind2rezeptoren |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis